MAR vs NMRA · P/E 32, rev $13.72B vs $283.5M cap
Marriott International Inc (MAR) versus Neumora Therapeutics, Inc. (NMRA) — a side-by-side from cached financials, not a winner call.
Marriott International Inc (MAR) is a lodging company listed on US.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Latest reported MAR revenue for 2026-06-30 was $13.72B. Net income was $1.41B. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
NMRA does not have a complete income-statement cache yet.
MAR currently screens at market cap $76.70B and trailing P/E 31.9. NMRA currently screens at market cap $283.5M.
Not investment advice. Open the MAR and NMRA stock pages for the full models.
Not investment advice.